NCT06775678View on ClinicalTrials.gov

Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

January 30, 2027

Study Completion Date

January 28, 2028

Conditions
Lung CancersRadiation Treatment for Tumors
Interventions
RADIATION

Spatially Fractionated Radiation Therapy Combined With Low-dose Radiotherapy

Spatially Fractionated Radiation Therapy Combined With Low-dose Radiotherapy

RADIATION

Conventional fractionated radiotherapy

Conventional fractionated radiotherapy

Trial Locations (1)

300000

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER